Your browser doesn't support javascript.
loading
[Current status of hypertension prevalence, treatment and control rate among young and middle-aged population in China].
Wang, X; Zhou, H H; Chen, Z; Zhang, L F; Zheng, C Y; Tian, Y; Shao, L; Zhu, M L; Wang, Z W; Gao, Runlin.
Afiliación
  • Wang X; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Zhou HH; Department of Biostatistics, School of Public Health, Peking University, Beijing 100083, China.
  • Chen Z; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Zhang LF; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Zheng CY; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Tian Y; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Shao L; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Zhu ML; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Wang ZW; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
  • Gao R; Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.
Zhonghua Xin Xue Guan Bing Za Zhi ; 50(12): 1169-1176, 2022 Dec 24.
Article en Zh | MEDLINE | ID: mdl-36517437
ABSTRACT

Objective:

To estimate the prevalence, awareness, treatment and control rate of hypertension among young and middle-aged population in China.

Methods:

The analysis was based on the results of 2012-2015 China Hypertension Survey, which was a cross-sectional stratified multistage random sampling survey. A total of 229 593 subjects were included in the final analysis. The data including sex, age, living in urban and rural areas, prevalence of hypertension, history of stroke, family history of coronary heart disease and drinking, physical examination, heart rate were collected. Hypertension was defined as mean systolic blood pressure (SBP) ≥140 mmHg (1 mmHg=0.133 kPa), and (or) diastolic blood pressure (DBP) ≥90 mmHg, and (or) self-report a history of hypertension, and (or) use of antihypertensive medicine within 2 weeks before survey. Prehypertension was defined as SBP between 120-139 mmHg, and (or) DBP between 80-89 mmHg. Control of hypertension was considered for hypertensive individuals with SBP<140 mmHg and DBP<90 mmHg. The prevalence of prehypertension, hypertension, awareness, treatment, control rate were calculated, and the control rate among those with antihypertensive medication was also calculated.

Results:

The prevalence of prehypertension and hypertension was 43.8% (95%CI 42.3%-45.4%), and 22.1% (95%CI 20.8%-23.3%), respectively. The prevalence of prehypertension and hypertension was significantly higher among male than female across different age groups. The awareness, treatment, control rate of hypertension and control rate among treated hypertensive participants were 43.8%, 33.2%, 16.7%, and 40.2%, respectively. The prevalence was higher, and the control rate was lower among individuals with higher heart rate.

Conclusion:

The prevalence of prehypertension and hypertension among young and middle-aged population is high, the awareness, treatment and control rate need to be further improved in this population. The prevention and treatment of hypertension should be strengthened in the future to improve the control rate of hypertension in China.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prehipertensión / Hipertensión Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Xin Xue Guan Bing Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prehipertensión / Hipertensión Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Xin Xue Guan Bing Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China